Stem Cell Sciences
StemCells Closes Australian Facility in Wake of SCS Acquisition
StemCells said the restructuring will support the growth of the stem cell culture and cell-based assay platforms it inherited as part of its estimated $4.8 million acquisition of SCS in April.
StemCells Completes SCS Acquisition
The $4.4 million acquisition provides StemCells with cell-based drug discovery technologies.
Short Reads: Mar 27, 2009
Premium
News in brief
Stem Cell Sciences Shareholders Support Sale to StemCells
SCS' shareholders voted in favor of the nearly $5 million deal.
StemCells plans to invest in Stem Cell Sciences' operational facilities in Cambridge, UK, in order to provide cell-based assay services to the drug discovery industry there, according to SCS' CEO.